vs
NCS Multistage Holdings, Inc.（NCSM）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
NCS Multistage Holdings, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.4倍（$50.6M vs $35.5M），NCS Multistage Holdings, Inc.净利率更高（29.5% vs -304.2%，领先333.8%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 12.5%），NCS Multistage Holdings, Inc.自由现金流更多（$12.9M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 7.4%）
NCS Multistage Holdings是一家全球能源技术与油田服务提供商，主营油气勘探生产用的完井系统与多级压裂工具，服务覆盖北美、拉美、中东及亚太市场，助力上游能源客户提升作业效率与资源采收率。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
NCSM vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $50.6M | $35.5M |
| 净利润 | $15.0M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 10.3% | -304.8% |
| 净利率 | 29.5% | -304.2% |
| 营收同比 | 12.5% | 681.7% |
| 净利润同比 | 331.0% | 39.6% |
| 每股收益（稀释后） | $5.43 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $50.6M | $35.5M | ||
| Q3 25 | $46.5M | $5.2M | ||
| Q2 25 | $36.5M | $19.2M | ||
| Q1 25 | $50.0M | $14.7M | ||
| Q4 24 | $45.0M | $4.5M | ||
| Q3 24 | $44.0M | $26.1M | ||
| Q2 24 | $29.7M | $14.4M | ||
| Q1 24 | $43.9M | $13.8M |
| Q4 25 | $15.0M | $-108.1M | ||
| Q3 25 | $3.8M | $-162.3M | ||
| Q2 25 | $924.0K | $-171.9M | ||
| Q1 25 | $4.1M | $-202.5M | ||
| Q4 24 | $3.5M | $-178.9M | ||
| Q3 24 | $4.1M | $-95.8M | ||
| Q2 24 | $-3.1M | $-97.5M | ||
| Q1 24 | $2.1M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 10.3% | -304.8% | ||
| Q3 25 | 6.6% | -3327.6% | ||
| Q2 25 | -5.6% | -916.8% | ||
| Q1 25 | 8.6% | -1297.9% | ||
| Q4 24 | 6.5% | -4042.4% | ||
| Q3 24 | 6.9% | -377.1% | ||
| Q2 24 | -14.0% | -697.4% | ||
| Q1 24 | 5.7% | -698.4% |
| Q4 25 | 29.5% | -304.2% | ||
| Q3 25 | 8.2% | -3135.3% | ||
| Q2 25 | 2.5% | -894.2% | ||
| Q1 25 | 8.1% | -1373.3% | ||
| Q4 24 | 7.7% | -3935.5% | ||
| Q3 24 | 9.4% | -367.5% | ||
| Q2 24 | -10.4% | -676.6% | ||
| Q1 24 | 4.7% | -662.4% |
| Q4 25 | $5.43 | $-0.17 | ||
| Q3 25 | $1.37 | $-0.36 | ||
| Q2 25 | $0.34 | $-0.41 | ||
| Q1 25 | $1.51 | $-0.50 | ||
| Q4 24 | $1.34 | $-0.56 | ||
| Q3 24 | $1.60 | $-0.34 | ||
| Q2 24 | $-1.21 | $-0.40 | ||
| Q1 24 | $0.82 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.7M | $743.3M |
| 总债务越低越好 | $5.3M | $9.6M |
| 股东权益账面价值 | $126.2M | $1.1B |
| 总资产 | $181.2M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.04× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $36.7M | $743.3M | ||
| Q3 25 | $25.3M | $659.8M | ||
| Q2 25 | $25.4M | $525.1M | ||
| Q1 25 | $23.0M | $500.5M | ||
| Q4 24 | $25.9M | $594.4M | ||
| Q3 24 | $15.3M | $427.6M | ||
| Q2 24 | $18.6M | $474.3M | ||
| Q1 24 | $14.0M | $296.3M |
| Q4 25 | $5.3M | $9.6M | ||
| Q3 25 | $5.1M | $11.9M | ||
| Q2 25 | $5.5M | $14.2M | ||
| Q1 25 | $5.4M | $16.4M | ||
| Q4 24 | $6.0M | $19.0M | ||
| Q3 24 | $6.5M | $20.5M | ||
| Q2 24 | $6.8M | $22.9M | ||
| Q1 24 | $6.4M | — |
| Q4 25 | $126.2M | $1.1B | ||
| Q3 25 | $110.1M | $1.0B | ||
| Q2 25 | $106.4M | $919.1M | ||
| Q1 25 | $103.2M | $933.9M | ||
| Q4 24 | $98.8M | $1.0B | ||
| Q3 24 | $96.0M | $524.6M | ||
| Q2 24 | $91.0M | $584.4M | ||
| Q1 24 | $93.7M | $401.2M |
| Q4 25 | $181.2M | $1.5B | ||
| Q3 25 | $162.0M | $1.4B | ||
| Q2 25 | $158.0M | $1.3B | ||
| Q1 25 | $155.1M | $1.3B | ||
| Q4 24 | $152.8M | $1.4B | ||
| Q3 24 | $145.8M | $726.5M | ||
| Q2 24 | $139.4M | $775.9M | ||
| Q1 24 | $140.9M | $557.8M |
| Q4 25 | 0.04× | 0.01× | ||
| Q3 25 | 0.05× | 0.01× | ||
| Q2 25 | 0.05× | 0.02× | ||
| Q1 25 | 0.05× | 0.02× | ||
| Q4 24 | 0.06× | 0.02× | ||
| Q3 24 | 0.07× | 0.04× | ||
| Q2 24 | 0.08× | 0.04× | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $12.9M | $-47.3M |
| 自由现金流率自由现金流/营收 | 25.5% | -133.1% |
| 资本支出强度资本支出/营收 | 0.4% | 3.5% |
| 现金转化率经营现金流/净利润 | 0.88× | — |
| 过去12个月自由现金流最近4个季度 | $21.0M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $13.1M | $-46.1M | ||
| Q3 25 | $7.2M | $-117.4M | ||
| Q2 25 | $3.5M | $-76.4M | ||
| Q1 25 | $-1.6M | $-132.0M | ||
| Q4 24 | $10.6M | $-115.4M | ||
| Q3 24 | $-2.0M | $-59.2M | ||
| Q2 24 | $6.0M | $-82.2M | ||
| Q1 24 | $-1.9M | $-102.3M |
| Q4 25 | $12.9M | $-47.3M | ||
| Q3 25 | $6.9M | $-117.6M | ||
| Q2 25 | $3.2M | $-79.6M | ||
| Q1 25 | $-2.1M | $-133.8M | ||
| Q4 24 | $10.4M | $-116.7M | ||
| Q3 24 | $-2.5M | $-63.8M | ||
| Q2 24 | $5.6M | $-83.4M | ||
| Q1 24 | $-2.2M | $-109.0M |
| Q4 25 | 25.5% | -133.1% | ||
| Q3 25 | 14.9% | -2272.5% | ||
| Q2 25 | 8.9% | -413.9% | ||
| Q1 25 | -4.2% | -907.4% | ||
| Q4 24 | 23.1% | -2567.7% | ||
| Q3 24 | -5.6% | -244.6% | ||
| Q2 24 | 19.0% | -578.5% | ||
| Q1 24 | -5.0% | -789.9% |
| Q4 25 | 0.4% | 3.5% | ||
| Q3 25 | 0.5% | 4.7% | ||
| Q2 25 | 0.8% | 16.4% | ||
| Q1 25 | 0.9% | 12.4% | ||
| Q4 24 | 0.5% | 28.6% | ||
| Q3 24 | 1.0% | 17.5% | ||
| Q2 24 | 1.1% | 8.2% | ||
| Q1 24 | 0.7% | 48.2% |
| Q4 25 | 0.88× | — | ||
| Q3 25 | 1.88× | — | ||
| Q2 25 | 3.81× | — | ||
| Q1 25 | -0.41× | — | ||
| Q4 24 | 3.07× | — | ||
| Q3 24 | -0.49× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.91× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NCSM
| Products | $33.8M | 67% |
| Services | $16.8M | 33% |
RXRX
暂无分部数据
